Home Articles List Article Information
ALEXMED ePosters
Journal Archive
Volume Volume 7 (2025)
Volume Volume 6 (2024)
Volume Volume 5 (2023)
Volume Volume 4 (2022)
Volume Volume 3 (2021)
Volume Volume 2 (2020)
Volume Volume 1 (2019)
Abousamra, A., Mahmoud, E., Said, A., Fahmy, A., Alshamy, S. (2024). ASSESSING QUALITY OF LIFE IN PATIENTS WITH GLAUCOMA USING THE GLAUCOMA QUALITY OF LIFE-15 QUESTIONNAIRE. ALEXMED ePosters, 6(2), 33-34. doi: 10.21608/alexpo.2024.296425.1858
Amir Aly Eldin Abousamra; Eman Abdellatif Mahmoud; Amr Ahmed Said; Ahmed Elsayed Fahmy; Sara Khalid Fawzy Alshamy. "ASSESSING QUALITY OF LIFE IN PATIENTS WITH GLAUCOMA USING THE GLAUCOMA QUALITY OF LIFE-15 QUESTIONNAIRE". ALEXMED ePosters, 6, 2, 2024, 33-34. doi: 10.21608/alexpo.2024.296425.1858
Abousamra, A., Mahmoud, E., Said, A., Fahmy, A., Alshamy, S. (2024). 'ASSESSING QUALITY OF LIFE IN PATIENTS WITH GLAUCOMA USING THE GLAUCOMA QUALITY OF LIFE-15 QUESTIONNAIRE', ALEXMED ePosters, 6(2), pp. 33-34. doi: 10.21608/alexpo.2024.296425.1858
Abousamra, A., Mahmoud, E., Said, A., Fahmy, A., Alshamy, S. ASSESSING QUALITY OF LIFE IN PATIENTS WITH GLAUCOMA USING THE GLAUCOMA QUALITY OF LIFE-15 QUESTIONNAIRE. ALEXMED ePosters, 2024; 6(2): 33-34. doi: 10.21608/alexpo.2024.296425.1858

ASSESSING QUALITY OF LIFE IN PATIENTS WITH GLAUCOMA USING THE GLAUCOMA QUALITY OF LIFE-15 QUESTIONNAIRE

Article 1, Volume 6, Issue 2, April 2024, Page 33-34  XML
Document Type: Preliminary preprint short reports of original research
DOI: 10.21608/alexpo.2024.296425.1858
View on SCiNiTO View on SCiNiTO
Authors
Amir Aly Eldin Abousamra1; Eman Abdellatif Mahmoud1; Amr Ahmed Said2; Ahmed Elsayed Fahmy3; Sara Khalid Fawzy Alshamy email 1
1Department of Ophthalmology, Faculty of Medicine, Alexandria University
2Ophthalmology department Alexandria University
3Department of Psychology, Faculty of Arts, Alexandria University
Abstract
Glaucoma is a chronic optic neuropathy, resulting in irreversible loss of the visual field and it is the second leading cause of irreversible blindness worldwide. Glaucoma is often asymptomatic and therefore recognized as the silent cause of blindness. It has a huge impact on a patient's life. Clinical measurements fail to fully describe activity limitations of glaucoma patients. Hence, a comprehensive assessment of the impact of the disease and its treatment on patients from their perspective has become important for the measurement of glaucoma impact and treatment outcomes.
A number of glaucoma-specific questionnaires or instruments have been developed in the past two decades. The Glaucoma Quality of Life-15 (GQL-15) questionnaire is concise and easy to administer
It is a 15 item, 4-domain tool that is short and easy to use.The instrument is based on the premise that perceived visual disability (dark adaptation, glare, outdoor mobility tasks and activities using peripheral vision) is significantly associated with binocular visual field loss.
Keywords
Glaucoma; quality of life (QOL); comprehensive assessment of the impact of the disease
Supplementary Files
Statistics
Article View: 73